Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2023. 10. 05.
 2007³â 1Â÷ ÀÌÁ¾Àå±â(ÆÇ¸·,ÆÇ¸·µµ°ü) ¿¬±¸¹ßǥȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2007.04.18. 15:06:29   Á¶È¸: 4463
2007³â 4¿ù 17ÀÏ ¿ÀÈÄ 6½Ã-9½Ã Grand Intercontinental Hotel ¿¡¼­
2007³âµµ Á¦1Â÷ ÀÌÁ¾Àå±â ÆÇ¸·, ÆÇ¸·µµ°ü¿¬±¸ ¹ßǥȸ¸¦ °³ÃÖÇÏ¿´´Ù.
¹ßÇ¥ ¿¬Á¦;
 
1. Introduction of xenograft tissue pressrvation : ±è¿ëÁø
2. Manufacturing process & LinX Treatment of SJM  THV ;
    Mark Bullivant, Director of Marketing, Cardiac Surgery,
    ST Jude Medical International  Division
3. Detoxification of GA-fixed pericardium & Various Methods
     for in vitro material assessment " ( calcium analysis,
     thermal denaturation temperture ,amino acid analysis,
     lipid content analysis ) ; ÀÌö
4. Role of Heparin in Bioprosthesis ; ¾çÁöÇõ
5. µÅÁöÀÇ ÆÇ¸·¿¡¼­ galactosidase ¸¦ ÀÌ¿ëÇÑ  a-Gal epitope
      Á¦°Å ; ¹Ú¼º½Ä
6. Sterilization effect of various reagents during fixation
      ; ÃÖâÈÞ
7. Plans for lage animal valve implantation experiments for
    systemic & pulmonic position ; ±è¿õÇÑ
8. Adjourn
 
 
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2023. 10. 05.  Àüü±Û: 208  ¹æ¹®¼ö: 1004409
58 ¹Ì±¹ÈäºÎ¿Ü°úÇÐȸ, ¼¼°è¼Ò¾Æ½ÉÀå¿Ü°úÇÐȸ °ü¸®ÀÚ2007.05.15.4331
57 2007³â 1Â÷ ÀÌÁ¾Àå±â(ÆÇ¸·,ÆÇ¸·µµ°ü) ¿¬±¸¹ßǥȸ °ü¸®ÀÚ2007.04.18.4463
56 Áß±¹¿¬º¯´ëÇÐ º¹Áöº´¿ø½ÉÀå¼ö¼úÁö¿ø °ü¸®ÀÚ2007.03.27.4471
55 Áß±¹ ÇϾóºó ¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.01.22.4476
54 ¹ÙÀÌ¿ÀÀÌÁ¾Àå±â ¿¬±¸¹ßǥȸ °ü¸®ÀÚ2006.12.21.4354
53 ¼±½Éȸ ¿¬¸»¸ðÀÓ ¹× È£³²¼øÈ¯±âÇÐȸ °ü¸®ÀÚ2006.12.13.4376
52 Áß±¹ ¼­¾È ¼­°æº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2006.11.20.4495
51 Á¦ 38Â÷ ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2006.11.08.4523
50 2006³â Ãß°è¼øÈ¯±âÇÐȸ °ü¸®ÀÚ2006.10.16.4967
49 Áß±¹ ¿¬±æ ¿¬º¯´ëÇб³ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2006.09.29.4528
RELOAD WRITE
 1 ¢¸ [11] [12] [13] [14] [15] 16 [17] [18] [19] [20]  ¢º 21